PHARMACOKINETICS, RELATIVE BIOAVAILABILITY AND FOOD EFFECT OF JZP-258 AND SODIUM OXYBATE: RESULTS OF TWO PHASE 1, OPEN-LABEL, RANDOMISED CROSSOVER STUDIES IN HEALTHY VOLUNTEERS

被引：0
|
作者：
Chen, C. [1 ]
Skowronski, R. [1 ]
Jenkins, J. [1 ]
Zomorodi, K. [1 ]
机构：
[1] Jazz Pharmaceut, Palo Alto, CA USA
来源：
SLEEP MEDICINE | 2019年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S65 / S66
页数：2
相关论文
共 50 条
  • [31] A randomized, open-label, two-treatment crossover study to evaluate the effect of food on the pharmacokinetics of diazepam nasal spray in healthy adults
    Rogawski, Michael A. A.
    Slatko, Gary
    EPILEPSIA, 2023, 64 (02) : 364 - 373
  • [32] Apixaban Pharmacokinetics and Bioequivalence of Two Tablet Formulations: A Randomized, Open-Label, Crossover Study, Fasting Condition in Healthy Indonesian Volunteers
    Leong, Chuei Wuei
    Yee, Kar Ming
    Liew, Ivan
    Khaleb, Nur Athirah
    Ahmad, Shahnun
    Rani, Tracy Ann
    Lau, Kheng Jim
    Yunaidi, Danang Agung
    Simanjuntak, Ronal
    Ginanjar, Vicky A.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (08): : 890 - 896
  • [33] Comparative study on the bioequivalence of two formulations of pravastatin - Data from a crossover, randomised, open-label bioequivalence study in healthy volunteers
    Almeida, S
    Filipe, A
    Almeida, A
    Gich, I
    Antonijoan, R
    Puntes, M
    Barbanoj, M
    Caturla, MC
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2006, 56 (02): : 70 - 75
  • [34] Two Phase 1, Open-Label, Mass Balance Studies to Determine the Pharmacokinetics of 14C-Labeled Isavuconazonium Sulfate in Healthy Male Volunteers
    Townsend, Robert
    Kato, Kota
    Hale, Christine
    Kowalski, Donna
    Lademacher, Christopher
    Yamazaki, Takao
    Akhtar, Shahzad
    Desai, Amit
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (02): : 207 - 216
  • [35] Ambroxol lozenge bioavailability - An open-label, two-way crossover study of the comparative bioavailability of ambroxol lozenges and commercial tablets in healthy Thai volunteers
    Rojpibulstit, M
    Kasiwong, S
    Juthong, S
    Phadoongsombat, N
    Faroongsarng, D
    CLINICAL DRUG INVESTIGATION, 2003, 23 (04) : 273 - 280
  • [36] Bioavailability and Pharmacokinetics of TRPV1 Antagonist Mavatrep (JNJ-39439335) Tablet and Capsule Formulations in Healthy Men: Two Open-Label, Crossover, Single-Dose Phase 1 Studies
    Manitpisitkul, Prasarn
    Shalayda, Kevin
    Russell, Lucille
    Sanga, Panna
    Williams, Yinka
    Solanki, Bhavna
    Caruso, Joseph
    Moyer, John A.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (07): : 699 - 711
  • [37] Erratum to: Increased bioavailability of phenylephrine by co-administration of acetaminophen: results of four open-label, crossover pharmacokinetic trials in healthy volunteers
    Hartley C. Atkinson
    Ioana Stanescu
    Isam I. Salem
    Amanda L. Potts
    Brian J. Anderson
    European Journal of Clinical Pharmacology, 2015, 71 : 771 - 772
  • [38] Pharmacokinetics and Safety of a 1:1 Mixture of Doxecitine and Doxribtimine: Open-label Phase 1 Single Ascending Dose and Food Effect Studies in Healthy Adults
    Mittur, Aravind
    VanMeter, Susan A.
    Orujov, Elmar
    Glidden, Paul
    CLINICAL THERAPEUTICS, 2024, 46 (07) : 576 - 587
  • [39] The Effect of Food on Tramadol and Celecoxib Bioavailability Following Oral Administration of Co-Crystal of Tramadol–Celecoxib (CTC): A Randomised, Open-Label, Single-Dose, Crossover Study in Healthy Volunteers
    Gregorio Encina
    Mercedes Encabo
    Marisol Escriche
    Mounia Lahjou
    Eric Sicard
    Kevin Smith
    Neus Gascon
    Carlos Plata-Salamán
    Sebastián Videla
    Clinical Drug Investigation, 2018, 38 : 819 - 827
  • [40] Bioavailability and Bioequivalence of Two Oral Formulations of Alendronate Sodium 70 mg: An Open-Label, Randomized, Two-Period Crossover Comparison in Healthy Korean Adult Male Volunteers
    Rhim, Si-Youn
    Park, Jin-Hee
    Park, Yoo-Sin
    Lee, Min-Ho
    Kim, Dong-Sun
    Shaw, Leslie M.
    Yang, Seok-Chul
    Kang, Ju-Seop
    CLINICAL THERAPEUTICS, 2009, 31 (05) : 1037 - 1045
12345